A podcast about Alzheimer's disease and related dementias
Frontotemporal dementia (FTD) is a type of dementia caused by degeneration in the temporal and frontal lobes of the brain. Our guest discusses the symptoms, risk factors, prevalence, and course of the disease, along with information on how a doctor diagnoses FTD and what families and caregivers can do after diagnosis.
Guest: Howard “Howie” Rosen, MD, behavioral neurologist at the University of California San Francisco Memory and Aging Center
People diagnosed with Alzheimer’s disease before the age of 65 are said to have early-onset Alzheimer’s disease. While this diagnosis is rare, the condition is very serious for the patient and their loved ones. Our guest helps define the disease and its symptoms, walks listeners through a diagnosis, and points to unique considerations for patients and their caregivers.
Guest: Susanne Seeger, MD, associate professor (clinical) of neurology, University of Wisconsin School of Medicine and Public Health
In the advancing field of dementia research, the rise in genetic and biomarker testing for Alzheimer’s disease creates a need for conversations around how to disclose disease risk to research participants who may be years away from experiencing the symptoms of the disease. Guest Dr. Shana Stites discusses her research that examines public perception of the disease, associated stigma and discrimination, and how the research and medical communities can support people who learn about their Alzheimer’s disease risk profile.
Guest: Shana D. Stites, PsyD, MS, Penn Memory Center, University of Pennsylvania Health System
On this week’s episode, Dr. Kimberly Mueller helps explain connected language and how studying conversations can help detect early signs of cognitive impairment.
Guest: Dr. Kimberly Mueller, Assistant Professor Department of Communications Sciences and Disorders, University of Wisconsin-Madison
Research has shown Alzheimer’s disease can be present in the brain decades before symptoms arise. Dr. James Lah discusses how he believes Alzheimer’s disease prevention should start in young and middle adulthood and shares with us what his vision of a cure might look like.
Guest: Dr. James Lah, MD, PhD, Associate Professor of Neurology, Alzheimer’s Disease Investigator, Emory University
Dr. Howard Federoff, a ground-breaking researcher of brain disorders, discusses his research relating to predicting Alzheimer’s disease through a blood test and shares his lifestyle habits for brain health.
Guest: Dr. Howard Federoff, MD, PhD, Researcher and Professor of Neurology at University of California, Irvine College of Medicine
Alzheimer’s disease-related changes occur in the brain more than 15 years before a person experiences the memory and personality changes associated with the disease. By studying the disease in its earliest stages, scientists hope to find treatments that can prevent or delay the onset of dementia and memory loss.
Guest: Sterling Johnson, PhD, Clinical Neuropsychologist, Professor of Geriatrics, University of Wisconsin School of Medicine and Public Health, Associate Director of the Wisconsin Alzheimer’s Disease Research Center, Principle Investigator of the Wisconsin Registry for Alzheimer’s Prevention (WRAP) Study
The thought of going in for a memory evaluation can be intimidating. Learn more about what you can expect with the evaluation process and get an idea of which behaviors are more concerning than others. In addition, learn why online assessments fall short when it comes to properly diagnosing memory concerns.
Guest: Lindsay Clark, PhD, neuropsychologist, UW Health Memory Assessment Clinic, and investigator, Wisconsin Alzheimer’s Disease Research Center
Recent research shows Alzheimer’s disease can be present up to two decades before symptoms occur; a phenomenon known as preclinical Alzheimer’s disease. Comparing the disease to a burning building, some scientists believe treatment needs to happen well before significant foundational damage occurs.
Guest: Paul Aisen, MD, Professor of Neurology and Director of the Alzheimer’s Therapeutic Research Institute, Keck School of Medicine, University of Southern California